Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
900.2 USD | +0.37% | +0.18% | +2.49% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.26% | 21.31B | |
-16.61% | 21.21B | |
-5.10% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B | |
+12.82% | 8.12B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals : HC Wainwright Adjusts Regeneron Pharmaceuticals' Price Target to $741 From $729, Keeps Buy Rating